Skip to Content
Merck
  • Plasma protein changes in rats treated with hypolipidaemic drugs and with phthalate esters.

Plasma protein changes in rats treated with hypolipidaemic drugs and with phthalate esters.

Human toxicology (1985-05-01)
R H Hinton, S C Price, F E Mitchell, A Mann, D E Hall, J W Bridges
ABSTRACT

Treatment of rats with hypolipidaemic drugs or with the plasticizer di-2-ethyl hexyl phthalate caused significant alterations in the concentration of certain plasma proteins. Certain proteins showed dose-dependent increases, in other cases the plasma concentrations fell in treated animals. The changes were quite distinct from the changes in plasma proteins which occur during the acute-phase response to inflammatory agents. Some changes appeared specific to agents which produce peroxisome proliferation in liver, other alterations appeared associated with mild, but sustained, liver injury.

MATERIALS
Product Number
Brand
Product Description

Supelco
Di-n-octyl phthalate, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Di-n-octyl phthalate, analytical standard
Sigma-Aldrich
Di-n-octyl phthalate, ≥98.0% (GC)